- Researchers from the National Cancer Institute (NCI) created an artificial intelligence (AI) tool “that uses data from individual cells” in tumors to predict patients’ response to a specific drug. The report was published in Nature Cancer.
- Purdue University researchers are developing nanoparticles capable of enhancing immunotherapy effects in cancer treatment. The study was published in ACS Nano.
- Researchers from the University of Pennsylvania gained insights into how cancer-caused liver inflammation hinders the immune system’s ability to fight cancer. The study was published in Nature Immunology.
- The researchers from Fred Hutchinson Cancer Center found that a specific type of bacteria, Fusobacterium nucleatum, known as related to gum disease, may promote colorectal cancer. These findings pave the way for therapies targeting these bacteria in colorectal cancer patients. The findings were published in Nature Immunology.
- Researchers from the University of Colorado Cancer Center explored the potential of a two-drug combination, doxorubicin plus bocodepsin, as a promising treatment option for triple-negative breast cancer. The preclinical study paves the way for future human clinical trials. The study was published in Breast Cancer Research.
- A new multicenter study found that women with early-stage triple-negative breast cancer who have high levels of immune cells in the tumor may be at a lower risk of recurrence and have better survival rates. The study was published today in the Journal of American Medical Association (JAMA).